Publications by authors named "Alvaro Padron"

Claim this Profile
A
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling.
Carlos O Ontiveros, Myrna G Garcia, Clare E Murray, Yilun Deng, Haiyan Bai, Alvaro Padron

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cocktail of SARS-CoV-2 spike stem helix domain and receptor binding domain human monoclonal antibodies prevent the emerge of viral escape mutants.
Yao Ma, Chengjin Ye, Michael S Piepenbrink, Sara H Mahmoud, Anastasija Cupic, Alvaro S Padron

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors.
Clare E Murray, Anand V R Kornepati, Carlos Ontiveros, Yiji Liao, Bárbara de la Peña Avalos, Alvaro S Padron

Mol Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects.
Haiyan Bai, Alvaro S Padron, Yilun Deng, Yiji J Liao, Clare J Murray

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic Lethality.
Anand V R Kornepati, Jacob T Boyd, Clare E Murray, Julia Saifetiarova, Bárbara de la Peña Avalos, Alvaro S Padron

Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents.
Clare Murray, Eva Galvan, Carlos Ontiveros, Yilun Deng, Haiyan Bai, Alvaro Souto Padron

Int J Mol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice.
Myrna G Garcia, Yilun Deng, Clare Murray, Ryan M Reyes, Alvaro Padron

Aging Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation.
Ryan M Reyes, Chenghao Zhang, Yilun Deng, Niannian Ji, Neelam Mukherjee, Alvaro S Padron

Oncoimmunology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,5-Diiodothyronine protects against cardiac ischaemia-reperfusion injury in male rats.
Ruy Andrade Louzada, Alvaro Souto Padron, Silvio Rodrigues Marques-Neto, Leonardo Maciel, João Pedro Werneck-de-Castro

Exp Physiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer.
Suzanne R Thibodeaux, Brian B Barnett, Srilakshmi Pandeswara, Shawna R Wall, Vincent Hurez

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation.
Ryan Michael Reyes, Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Alvaro S Padron

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy.
Deyi Zhang, Ryan M Reyes, Erica Osta, Suresh Kari, Harshita B Gupta, Alvaro S Padron

Cancer Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer.
Harshita B Gupta, Curtis A Clark, Bin Yuan, Gangadhara Sareddy, Srilakshmi Pandeswara, Alvaro S Padron

Signal Transduct Target Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade.
Justin M Drerup, Yilun Deng, Sri Lakshmi Pandeswara, Álvaro S Padrón, Ryan M Reyes

Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for successful cancer immunotherapy in aged hosts.
Vincent Hurez, Álvaro Padrón, Robert S Svatek, Tyler J Curiel

Exp Gerontol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model.
Álvaro Padrón, Vincent Hurez, Harshita B Gupta, Curtis A Clark, Sri Lakshmi Pandeswara

Exp Gerontol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment.
Yang Liu, Srilakshmi Pandeswara, Vinh Dao, Álvaro Padrón, Justin M Drerup

Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.
Curtis A Clark, Harshita B Gupta, Gangadhara Sareddy, Srilakshmi Pandeswara, Shunhua Lao, Alvaro Padron

Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice.
Vincent Hurez, Vinh Dao, Aijie Liu, Srilakshmi Pandeswara, Jonathan Gelfond

Aging Cell· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for ovarian cancer.
Justin M Drerup, Yang Liu, Alvaro S Padron, Kruthi Murthy, Vincent Hurez

Curr Treat Options Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues.
Alvaro Souto Padron, Ruy Andrade Louzada Neto, Thiago Urgal Pantaleão, Maria Carolina de Souza dos Santos, Renata Lopes Araujo

J Endocrinol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of serum estradiol and leptin levels on thyroid function, food intake and body weight gain in female Wistar rats.
Thiago U Pantaleão, Felippe Mousovich, Doris Rosenthal, Alvaro S Padrón, Denise P Carvalho

Steroids· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MTOR downregulates iodide uptake in thyrocytes.
Elaine Cristina Lima de Souza, Alvaro Souto Padrón, William Miranda Oliveira Braga, Bruno Moulin de Andrade, Mário Vaisman

J Endocrinol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of acute exercise session on thyroid hormone economy in rats.
Rodrigo Soares Fortunato, Daniele Leão Ignácio, Alvaro Souto Padron, Ramon Peçanha, Michelle Porto Marassi

J Endocrinol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis